Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Syndax Pharmaceuticals Inc (SNDX)
NASDAQ:SNDX
RESEARCH TOOLSreports
Holding SNDX?
Track your performance easily
SNDX Analyst Ratings
Strong Buy
11 Buy
1 Hold
0 Sell
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months
SNDX Stock 12 Month Forecast
Average Price Target
$36.80
▲(158.97% Upside)
| Highest Price Target$51.00 | Average Price Target$36.80 | Lowest Price Target$16.00 |
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.
Detailed List of Analyst Forecasts
Ranks
Any
Analyst Rating
Any
Upside/ Downside
Any
Action
Any
Stifel Nicolaus
Reiterated
01/31/25
BTIG
Reiterated
01/22/25
Bank of America Securities
Reiterated
01/14/25
Barclays
Assigned
01/14/25
Scotiabank
Reiterated
01/08/25
Jefferies
Reiterated
01/06/25
J.P. Morgan
Reiterated
12/17/24
TD Cowen
Reiterated
12/10/24
H.C. Wainwright
Reiterated
12/10/24
Mizuho Securities
Reiterated
12/09/24
Citi
$37→$45
Buy
216.68%
Upside
Reiterated
11/19/24
Syndax price target raised to $45 from $37 at CitiSyndax price target raised to $45 from $37 at Citi
Goldman Sachs
$33→$31
Buy
118.16%
Upside
Reiterated
11/13/24
Syndax Pharmaceuticals (SNDX) PT Lowered to $31 at Goldman SachsGoldman Sachs analyst Chris Shibutani lowered the price target on Syndax Pharmaceuticals (NASDAQ: SNDX) to $31.00 (from $33.00) while maintaining a Buy rating.
UBS
$37
Buy
160.38%
Upside
Initiated
10/24/24
Syndax initiated with a Buy at UBSSyndax initiated with a Buy at UBS
B.Riley Financial
$36
Buy
153.34%
Upside
Reiterated
10/09/24
B.Riley reiterates Buy Rating on Syndax Pharmaceuticals (SNDX)B.Riley analyst Kalpit Patel reiterated a Buy rating and $36.00 price target on Syndax Pharmaceuticals (NASDAQ: SNDX).
Best Analysts Covering Syndax Pharmaceuticals
Which Analyst Should I Follow If I Want to Buy SNDX and Sell After:
1 Month
xxx
Success Rate
7/13 ratings generated profit
Average Return
+1.33%
reiterated a xxx
rating 10 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 53.85% of your transactions generating a profit, with an average return of +1.33% per trade.
3 Months
xxx
Success Rate
10/17 ratings generated profit
Average Return
+10.10%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 58.82% of your transactions generating a profit, with an average return of +10.10% per trade.
1 Year
Success Rate
10/17 ratings generated profit
Average Return
+27.48%
reiterated a buy rating 3 months ago
Copying Chris Shibutani's trades and holding each position for 1 Year would result in 58.82% of your transactions generating a profit, with an average return of +27.48% per trade.
2 Years
xxx
Success Rate
8/17 ratings generated profit
Average Return
+33.50%
reiterated a xxx
rating 3 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 47.06% of your transactions generating a profit, with an average return of +33.50% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.
SNDX Analyst Recommendation Trends
Rating
Sep 24
Oct 24
Nov 24
Dec 24
Jan 25
Strong Buy
12
14
18
25
26
Buy
10
7
8
10
10
Hold
1
1
3
3
4
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
23
22
29
38
40
Each month's total comprises the sum of three months' worth of ratings.
SNDX Financial Forecast
SNDX Stock Forecast FAQ
What is SNDX’s average 12-month price target, according to analysts?
Based on analyst ratings, Syndax Pharmaceuticals Inc’s 12-month average price target is $36.80.
What is SNDX’s upside potential, based on the analysts’ average price target?
Syndax Pharmaceuticals Inc has 158.97% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is SNDX a Buy, Sell or Hold?
Syndax Pharmaceuticals Inc has a consensus rating of Strong Buy which is based on 11 buy ratings, 1 hold ratings and 0 sell ratings.
What is Syndax Pharmaceuticals Inc’s price target?
The average price target for Syndax Pharmaceuticals Inc is $36.80. This is based on 12 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $51.00 ,the lowest forecast is $16.00. The average price target represents 158.97% Increase from the current price of $14.21.
The highest analyst price target is $51.00 ,the lowest forecast is $16.00. The average price target represents 158.97% Increase from the current price of $14.21.
What do analysts say about Syndax Pharmaceuticals Inc?
Syndax Pharmaceuticals Inc’s analyst rating consensus is a Strong Buy. This is based on the ratings of 12 Wall Streets Analysts.
How can I buy shares of SNDX?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.